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Summary  
The presence and distribution of tumor necrosis factor-~ (TNF-~), TNF receptors and stromelysin [matrix 
metalloproteinase 3 (MMP-3)] in articular cartilage were evaluated in an iatrogenically induced model of osteoarthritis 
(OA). Eleven adult male dogs were assigned randomly to a control group (N= 4) or an OA group (N= 7). Osteoarthritis 
was created by surgical transection of the cranial cruciate ligament of one stifle joint. Both femoral condyles were 
sampled 3months post-surgery atnecropsy and immunohistochemically nalyzed for the presence of the aforementioned 
cytokines and receptors. Chondrocytes stained for TNF-~ and TNF receptors in control articular cartilage, spanning 
an area encompassing most of the middle and deep zones. Positive matrical and chondrocytic staining for TNF-a, TNF 
receptors, and stromelysin was present in OA articular cartilage. Staining varied in intensity and distribution and was 
dependent on the severity of the lesion. Smooth muscle cells of arteries and arterioles (periarticular synovial 
membrane) were stained for only one (p55) of two TNF receptors; this staining was confined to control tissues. Results 
indicate that the differential expression of TNF-a and its receptors may be important in the normal maintenance of 
articular cartilage. The increased presence of TNF-a and its receptors in articular cartilage with mild osteoarthritic 
changes uggests a role in the development of early OA. Regulating TNF-a may be an important component in the 
treatment of OA. 
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I n t roduct ion  
TUMOR NECROSIS FACTOR-0. r (TNF-~) is a 17kDa 
cytok ine produced by a var iety  of cells inc luding 
macrophages  and act ivated lymphocytes [1] and 
neutrophi ls  [2]. I t  is h ighly conserved among 
species with human TNF-~, shar ing approx imate ly  
79% sequence homology  with mice [3] and 92% 
with dogs [4]. The biological  effect of TNF-a is 
mediated through b inding to its two surface 
membrane  receptors  (p55 MW = 55 kDa and 
p75 MW = 75 kDa). These receptors  are found on 
the surface of most  mammal ian  cells [5], including 
ar t i cu la r  chondrocytes [6]. The extrace l lu lar  
domains of the receptors  hare approx imate ly  28% 
sequence homology and bind TNF-a and TNF-fl 
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with equal  affinity. However, the in t race l lu la r  
port ions  of the receptors  are unrelated,  ind icat ing 
separate  s ignal  t ransduct ion  pathways [7]. B inding 
to p55 is apparent ly  required for most  TNF-~- 
mediated biological  responses including growth 
s t imulat ion  of f ibroblasts, cytotoxic  s ignal  trans- 
duct ion in certa in tumor  cell l ines, and endotox in  
shock in vivo [8-10]. St imulat ion of the p75 
receptor  esults  in thymocyte  prol i ferat ion [10]. In 
addit ion, act ivat ion of the p75 receptor  has  been 
shown to mediate direct ly cytotoxic i ty in KYM-1 
rhabdomyosarcoma cells, as well as ind i rect ly  
augment ing  the cytotoxic  effect on U937 hist iocy- 
toma cells. The p75 receptor  also potent iates  p55 
receptor - induced signal  t ransduct ion  leading to 
act ivat ion of the CMV promoter  in cer ta in  tumor  
cell l ines [11]. 
The p le iotrophic  act iv i t ies of TNF-~ are gener- 
al ly catabol ic  and play a major  role in degradat ive 
condit ions such as osteoarthr i t i s  (OA) [12-16] 
and in f lammatory  auto immune diseases such as 
rheumato id  ar thr i t i s  (RA) [17-20]. In OA, TNF-~ 
contr ibutes  to the instabi l i ty  of the ar t i cu la r  
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cart i lage matr ix  by inhib i t ing proteoglycan syn- 
thesis [21] and up-regulat ing matr ix  metal lo-  
prote inase (MMP) enzymes capable of matr ica l  
degradat ion [16,22,23]. Compared with other  
members  of the MMP family, MMP-3 (stromelysin) 
has been impl icated as one of the major  enzymes 
involved in degradat ion  of the matr ix  of a r t i cu la r  
cart i lage in OA [22]. Tumor  necrosis factor-~ has a 
strong st imulatory  effect on MMP-3 since it has 
been reported to produce a 10-fold up-regulat ion of 
MMP-3 activit ies [24]. In addit ion to its inf luence 
on MMP enzymes, TNF-~ is thought  o play a major  
role in perpetuat ing  inf lammation.  Human syn- 
ovial f ibroblasts t reated with TNF-~ show 
an induced expression of mRNAs for var ious  
chemotact ic  factors  [25], and endothel ia l  cells 
are act ivated by TNF-~ as demonstrated by the 
detect ion of adhesion molecules l ike ELAM-1 [26]. 
The biological  effects of TNF-~ are inhib i ted by 
the binding of TNF-a to shed port ions of p55 and 
p75 cell surface receptors.  These two 30kDa 
soluble proteins have been descr ibed in the 
synovial  fluid of both RA and OA pat ients  [27, 28] 
and in the serum of pat ients  suffer ing f rom a 
var iety of connect ive t issue and auto immune 
diseases [29]. In addit ion, e levated levels of shed 
TNF  receptors  have been repor ted  in post-operat ive 
surgery pat ients  [30]. The exact  funct ion of these 
soluble receptors  is unknown,  but it is postu lated 
that  they counteract  the systemic effects of TNF-e 
dur ing in f lammat ion or in jury  [27, 28, 30, 31]. 
Contro l  of local ized in teract ions  between TNF-a 
and TNF  receptors  is an area  of cur rent  interest  for 
the t reatment  of in f lammatory  disease. In arthr i t is ,  
ant i -TNF-e therapy has been used pr imar i ly  in 
RA due to the extensive in f lammat ion  assoc iated 
with its pathogenesis  [32, 33]. OA, on the other  
hand,  is general ly  not  cons idered to be a pr imary  
, in f lammatory  disease, s ince the dest ruct ion  of 
t issue is thought  to resul t  f rom mechan ica l  injury, 
and in f lammat ion occurs  secondary  to dest ruct ion  
of the ar t i cu lar  cart i lage [34]. Thus, a l though 
TNF-e has been studied in OA, emphasis  has been 
focused on its role in exacerbat ion  of a r t i cu la r  
cart i lage dest ruct ion  due to the secondary  inflam- 
matory  response rather  than  its potent ia l  role as a 
pr imary  mediator  of cart i lage degradat ion  [35]. 
However, the assoc iat ion between TNF-e and 
chondrocyt ic  hydrolyt ic  enzymes capable of art icu- 
lar  cart i lage dest ruct ion  supports  a potent ia l  
Table I. 
Histological scoring scheme for osteoarthritis lesions in articular cartilage 
Matrix Cell 
morphology morphology 
Matrix staining 
Haematoxylin and eosin Toluidine blue 
Normal = 0 
Uneven surface (may be 
bulging out in some areas)= 1
Slight surface erosion (no 
deeper than tangential 
zone) = 2 
Deeper surface erosion with 
or without fissuring (extend- 
ing into middle zone)= 3 
Erosion or fissuring into deep 
zone = 4 
Severe erosion into the zone 
of calcified cartilage = 5 
Erosion down into subchon- 
dral bone = 6 
Normal = 0 
Enlarged, circular ap- 
pearance of chondrocytes 
(superficial tangential or 
middle zone) = 1 
Slight hypercellularity 
with or without small 
clone formation (2-3 
chondrocytes per 
group) = 2 
Hypercellularity with or 
without large clone for- 
mation (4 or more per 
group) = 3 
Severe hypocellularity 
(may see) clones or ab- 
sence of cells in lesion, 
with excess hypercellu- 
larity and clone for- 
mation in areas 
immediately adjacent o 
the lesion = 4 
Normal = 0 
Washed-out appearance 
of cartilage (superficial 
tangential zone) = 1 
Washed-out appearance 
of cartilage (middle 
zone) with some in- 
creased acidophilia in 
superficial tangential 
zone = 2 
Extreme acidophilia 
which can extend down 
through the deep 
zone = 3 
Normal = 0 
Decreased metachro- 
masia (superficial tan- 
gential zone) = 1 
Decreased metachro- 
masia (superficial tan- 
gential zone and at least 
half of the middle 
zone) = 2 
Decreased metachro- 
masia (down into the 
deep zone) = 3 
Absence of metachro- 
masia = 4 
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primary role of TNF-a in the early pathogenesis of 
OA. Because of this 'relationship, the present study 
was conducted to evaluate the distribution of TNF-~ 
and its receptors in early degenerative changes 
associated with OA using a canine model of OA. 
Mater ia l s  and  Methods  
This study was conducted under a protocol 
approved by the Auburn University Institutional 
Care and Use Committee. Dogs were obtained 
through approved sources by the Division of 
Laboratory Animal Resources of the College of 
Veterinary Medicine at Auburn University. Eleven 
healthy adult male hound-type dogs weighing 
18-26.4 kg were used. Throughout he study, dogs 
were housed in individual runs, fed a balanced 
commercial diet, and allowed water ad libitum. Both 
stifle joints were radiographed to insure complete 
closure of physes and absence of skeletal abnormal- 
ities. The dogs were randomly assigned into two 
groups: (1) OA (transected cranial cruciate liga- 
ment, N= 7), and (2) control (unoperated, N= 4). We 
found it unnecessary to include a sham-operated 
control group, based on the biochemical and 
histological findings of Myers et al. [36]. In that 
study, no significant changes in the articular 
cartilage were noted for sham-operated controls as 
long as, hemostasis was carefully followed. 
OA was created by surgical destabilization of the 
left stifle joints. In preparation for anesthesia each 
dog was administered atropine sulfate (0.01 mg/kg, 
subcutaneous injection), and acetylpromazine 
maleate (0.1 mg/kg, intramuscular injection). Anes- 
thesia was induced and maintained with sodium 
pentothal (2.5% solution) administered through an 
18-gauge angiocatheter. A medial arthrotomy and 
subsequent ransection Of the cranial cruciate 
ligament was performed through a mid-sagittal skin 
incision (approximately 2-3 cm in length) made over 
the patellar ligament [36, 37]. 
At 12 weeks post-surgery, each dog was eutha- 
nized with an intravenous overdose of pentobarbital 
(18mg/kg). The joint capsule and accessory 
structures (e.g. menisci, ligaments and patella) were 
removed. Individual 5 mm wedged-shaped slabs of 
articular cartilage and accompanying subchondral 
bone were excised from the junction of the medial 
trochlear idge and medial condyle of each femur; in 
some cases portions of periarticular synovial 
membrane were attached. Specimens were placed in 
neutral buffered 10% formalin (pH 7.4) for 72 h at 
room temperature. After decalcification in an 8% 
mixture of concentrated hydrochloric and formic 
acids at room temperature, specimens were washed 
for 1 h in running tap water and processed for 24 h 
using a vacuum infiltration tissue processor. 
Specimens were embedded in a high-polymer plastic 
paraffin and serial sectioned at a thickness of 5 pm 
using a rotary microtome (Reichert-Jung 2050 
microtome.). Slides were routinely stained with 
hematoxylin and eosin (H&E) and toluidine blue. 
Sections were evaluated for the presence of 
degenerative changes using a modification of the OA 
scoring procedure by Van Der Sluijs et al. [38] to 
classify early articular cartilage changes into 
general categories (Table I). Samples were graded on 
a scale of 0-17 (mi ld=l-5,  moderate=6-11, 
severe = 12-17) by a single individual. 
ANTIBODY CHARACTERIZATION 
Polyclonal rabbit anti-human anti-TNF anti- 
bodies for immunohistochemical localization of 
TNF-~ were purchased from Sigma Inc., St Louis, 
MO, U.S.A. (and Genzyme Diagnostic Inc., Cam- 
bridge, MA, U.S.A.). Cross-reactivity with canine 
protein was determined according to the following 
protocol. Twenty milliliters of heparinized human 
or dog blood was diluted 1:1 with phosphate 
buffered saline (PBS), layered over 10 ml lympho- 
cyte separation medium (Bionetics, Kensington, 
MD, U.S.A.) and centrifuged at room temperature 
for 30min at 600g. The monocyte layer was 
collected and resuspended in 15 ml RPMI medium 
containing 10% fetal calf serum. Cells were washed 
twice in the same medium and resuspended at 
2x106 cells/ml in medium containing 10ttg/ml 
lipopolysaccharide and incubated for 6 h at 37°C in 
a 5% CO2/95% air incubator. Cells were harvested 
by centrifugation, washed twice with 15 ml PBS 
and dissolved in 0.025 M Tris, pH 6.8 containing 
0.08% glycerol, 1% sodium dodecyl sulphate, 
0.025% mercaptoethanol by boiling for 10min. 
Western blot analysis was performed using rabbit 
anti-human TNF-a antisera on both. A 17 kDa band 
was detected by the two antibodies in both human 
and canine samples. 
The Genzyme antibody also binds human and rat 
TNF-a. Ten microliters of this antibody neutralizes 
apprSximation 1000 units of TNF-~ bioactivity as 
observed in the L929 cell cytotoxicity assay. In 
addition, cross-reactivity with this antibody and 
canine tissue was determined by Pickvance et al. 
[39]. The TNF receptors were characterized using 
rabbit anti-human polyclonal proteins for p55 
and p75 (a gift from Jerry Ranges of Bayer Inc.). 
Specifity of these antibodies was determined using 
western blot and enzyme-linked immunosorbent 
assay analysis. MMP-3 was detected by using a 
mixture of three mouse antibodies (IgG1 mono- 
clonals, a gift from Scott Wilhelm of Bayer Inc.). 
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~These antibodies were raised against different 
domains of the 58 kDa zymogen and 45 kDa-active 
enzyme of human fibroblast MMP-3. Western blot 
-analysis demonstrated cross-reactivity with a 
58 kDa band from cultured canine chondrocytes. 
IMMUNOHISTOCHEMICAL STAINING 
In serial tissue sections, antibodies to TNF-~ 
(1:100), MMP-3 (1:500), p55 (1:200) and p75 
(1:200) were used in a PBS buffer to detect their 
corresponding proteins. Sections for the various 
proteins were deparaffinized and rehydrated in 
distilled water, followed by digestion for I h in 
hyaluronidase (1.0mg/ml, Sigma Chemical Co.). 
Then 1.5% methanol in hydrogen peroxide was 
applied for 45 min, followed by serum blocking with 
normal goat serum (10%) or normal horse serum 
(10%) for 20 min. Primary antibodies were applied 
and allowed to incubate overnight at room 
temperature. 2 ABC Elite kits (Vector Labs Inc.) 
utilizing biotintylated antibodies were used to 
label the primary antibodies. ~ The use of 3,3'- 
diaminobenzidine hydrochloride (DAB) gave a 
colored reaction. 4 Serial sections of rheumatoid 
arthritic synovium was used as the positive control 
for all antibodies. In all cases the substitution of 
PBS for the primary antibody served as the 
negative control. 
Resu l ts  
CONTROLS 
The articular cartilage was usually devoid of 
any surface disruptions. Normal metachromatic 
and H&E staining was observed in most cases. 
Chondrocytic staining was intensely basophilic 
and metachromatic, while matrical staining 
exhibited uniform metachromasia nd balanced 
basophilia/acidophilia. In a few instances, 
degenerative areas indicative of matrix break- 
down were observed. These degenerative areas 
had decreased metachromasia and increased 
acidophilia [Fig. I(A) and (B)]. 
Immunostaining for TNF-~ was present in 
chondrocytes from the middle, including the 
calcified cartilage zones, with the strongest 
straining located in the deep and calcified cartilage 
zones. Staining of the articular cartilage matrix 
was negative unless matrical breakdown occurred. 
~Anti-TNF-~, Sigma Chemical Co. Anti-p55, anti-p75, a gift 
from Jerry Ranges, Miles Inc. Anti-stromelysin, a gift from Scott 
Wilhelm, Miles Inc. 
~ABC Elite kit, Vector Labs Inc. 
4Glucose oxidase, Vector Labs Inc. DAB, Sigma Chemical Co. 
Then chondrocytes had moderate to heavy TNF-~ 
staining [Fig. 1(C)]. 
Both TNF receptors had the same weak staining 
pattern, except the staining intensity of p75 was 
less than p55. Scattered chondrocytes were moder- 
ately to heavily stained, except when matrical 
breakdown had occurred [staining pattern was 
similar to Fig. 1(C)]. Areas of matrical breakdown 
had moderate to dark staining of the matrix and 
chondrocytes which corresponded to regions of 
TNF-~ matrical staining. 
Staining for stromelysin was negative unless 
matrical breakdown was present. Articular carti- 
lage in these areas had moderate :matrical and 
moderate to dark chondrocytic staining for 
stromelysin. 
OA LESIONS 
In all instances the operated stifle exhibited 
moderate to severe lesions, whereas the contralat- 
eral stifle developed mild to moderate lesions. 
Mild changes in the superficial tangential zone 
of the articular cartilage were characterized by 
increased acidophilia (H&E) and decreased 
metachromasia of the matrix. Hypertrophy of some 
chondrocytes was also present [Fig. I(E) and (F)]. 
Articular cartilage of moderate OA lesions had 
decreased metachromatic staining with a corre- 
sponding increased acidophilia and thickening of 
the subchondral bone [Fig. 1(I) and (J)]. In severe 
lesions, the matrix had minimal or a complete 
absence of metachromatic staining with dramatic 
acidophilia. Subchondral bone was thickened and 
appeared denser. Lesion areas also exhibited 
chondrocytic clone formation and, in some in- 
stances, hypercellularity. 
TNF-0~ 
Immunostaining of serial sections with TNF-~ 
paralleled both the increased acidophilic and 
decreased metachromatic staining associated with 
OA. Mild OA cartilage had moderate to heavy 
matrical staining for TNF-~ [Fig I(G)]. 
Fibrillated OA cartilage had heavy matrical 
staining with moderate to heavy chondrocytic 
staining in the deep zone. Mononuclear cells of 
periarticular synovial membrane and areas of 
peripheral osteophyte formation, as well as marrow 
cells associated with osteophytes, had positive 
staining. 
P55 RECEPTOR 
In fibrillated OA articular cartilage, staining for 
p55 receptors was heavy. Matrical staining was 
restricted to the superficial tangential zone (STZ) 
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FIG. 1. Low magnification photomicrographs of control articular cartilage. (A) Hematoxylin and eosin (H&E). (B) 
Toluidine blue (T. blue). Immunolocalization of (C) tumor necrosis factor-~ and (]9) stromelysin [matrix 
metalloproteinase 3 (MMP-3)]. Low magnification views of early mild osteoarthritis (OA) changes. (E) H&E. (F) T. Blue. 
Immunolabeling of (G) TNF-a and (H) MMP-3. Low power photomicrographs of early moderate OA changes. (I) H&E. 
(J) T. Blue. Immunolocalization f (K) TNF-~ and (L) MMP-3. 
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FIG. 2. Immunolocalization f p55 (A) and p75 (B) in chondrocytes of severe osteoarthritis lesions. 
and the outer 10% of the middle zone. Chondrones, 
when present, had moderate to dark intracellular 
staining [Fig. 2(A)]. 
The chondrocytes in hypercellular articular 
cartilage had moderate to dark intracellular 
staining throughout. Heaviest staining was 
located in the STZ and middle zones. The 
remainder of the articular cartilage had light 
chondrocytic staining, primarily in  the STZ 
and outer portions of the middle zone. Hyper- 
cellular articular cartilage had increased intra- 
cellular staining had spanned most of the layers, 
irrespective of surface erosion. Positive p55 
staining was also seen in the periarticular synovial 
membrane in mononuclear cells of unknown 
ident i ty [Fig. 3(A)], areas of peripheral osteophyte 
formation, some cells of the marrow cavity 
associated with osteophytes, and smooth 
muscle cells of blood vessels in control tissue 
[Fig. 4(A)]. 
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FIG. 3. Immunolocalization f p55 (A) and p75 (B) in mononuclear cells of osteoarthritis synovial membrane. 
P75 RECEPTOR 
Staining pattern was similar to that of p55, but 
lighter in intensity [Figs. 2(B), 3(B) and 4(B)]. 
STROMELYSIN 
Matrical and intracellular staining patterns of 
osteoarthrit ic artilage were similar to those of 
TNF-a-stained OA cartilage, but darker. Mild OA 
lesions had matrical staining and moderate to dark 
chondrocytic staining [Fig. I(H)]. Hypercellular 
articular cartilage exhibited very light chondro- 
cytic and matrical staining of the STZ and upper 
portion of the middle zone. 
t tYPERCELLULAR ARTICULAR CARTILAGE 
Closer examination of hypercellular areas re- 
vealed apparent gradations in the ontogeny of OA 
lesions. Hypercellular articular cartilage that 
retained most of its metachromatic staining and 
demonstrated only mild acidophilia exhibited 
increased chondrocytic staining for both TNF 
receptors, increased matrical and chondrocytic 
staining for TNF-a [Fig. 1(E-H)], but very light 
matrical and chondrocytic staining for stromelysin. 
Matrical staining for stromelysin was confined to 
areas of cartilage that had decreased metachro- 
masia. Chondrocytic staining of stromelysin was 
also more pronounced in these areas. 
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FIG. 4. Immunolocalization f p55 (A) and p75 (B) in smooth muscle nuclei of synovial blood vessels of control tissue. 
Hypercellular articular cartilage with decreased 
metachromatic staining and increased acidophilia 
(approximately 50% of the articular cartilage 
overall) exhibited a marked decreased in both 
matrical and chondrocytic staining for TNF 
receptors, a further increase in both matrical 
and chondrocytic staining for TNF-~ [Fig. 1(I-K)], 
and a marked increase in both chondrocytic and 
matrical staining for stromelysin [staining pattern 
similar to the STZ and outer middle zone of TNF-~, 
Fig. l(L)]. 
Discuss ion  
Evaluation of OA lesions using the Mankin 
scoring system [40] or a modification of its criteria 
[38] has provided a valuable tool for the character- 
ization of the pathogenesis of OA. However, these 
scoring systems do not address the early or subtle 
degenerative matrical changes (without surface 
disruption) observed. Thus, modifications of pre- 
vious scoring systems used in this study reflected 
early Changes in the cartilage and allowed 
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classification i to one of three categories based on 
severity: mild, moderate, or severe. 
The histological results of our study substantiate 
the existence of early subtle matrical changes in 
the etiopathogenesis of OA and provide insight into 
the chronology of these changes. Certain cytokines 
such as TNF-~ may have a more primary role in the 
homeostasis of normal articular cartilage. How- 
ever, the function of these cytokines is probably 
tightly controlled. This is exemplified by TNF-a 
which is produced in a proform that must undergo 
enzymatic cleavage prior to activation [41]. In 
response to an initial disruption of the chondro- 
cyte-matrix complex by an insult such as mechan- 
ical trauma, stored chondrocytic pools of TNF-a 
may become activated and bind with TNF cellular 
receptors, stimulating an increase in chondrocytic 
TNF receptor expression [19]. As increased levels 
of TNF-~ are produced and secreted into the 
extracellular matrix, the production of MMPs (i.e. 
stromelysin) by chondrocytes i stimulated. The 
synergistic action of TNF-~ and stromelysin 
increases the degradation of proteoglycans that 
exacerbates the degeneration i itiated by mechan- 
ical trauma [16]. As aggregating proteoglycans 
are lost and collagen is degraded, the articular 
cartilage swells. At some point, the articular 
cartilage makes an attempt at repair by increasing 
the production of proteoglycans [42], but the 
damage is too great and the repair response is 
overwhelmed. 
In support of this concept is the observation that 
early osteoarthritic lesions observed in the present 
study had a similar pattern of histological features 
regardless of severity characterized by regions of 
articular carti lagewith decreased metachromasia 
and increased acidophi!ic matrical staining. 
Immunolocalization f TNF-~ generally paralleled 
the decreased metachromatic and increased 
acidophilic staining patterns for OA lesions. This 
suggested a positive relationship between lesion 
development and up-regulation of TNF-~ in the OA 
cartilage matrix. 
As hypothesized above, the early pathogenesis of
OA entails a series of progressive, yet definable, 
stages. Two of these stages are illustrated by the 
appearance of control articular cartilage and its 
comparison to hypercellular articular cartilage. In 
control articular cartilage, chondrocytes stained 
intensely for TNF-~ in the deep-middle and deep 
zones of articular cartilage. However, matric TNF-a 
staining was absent unless apparent degradation 
had occurred. This intracellular localization in 
normal cartilage suggested a potential regulatory 
activity of TNF-~, as well as, its well-characterized 
catabolic functions in OA [43-47]. Unlike the 
results of the present study, Shinmei et al. [16] and 
Pickvance et al. [39] reported either occasional 
positive or total absence of chondrocytic staining 
for TNF-a in control articular cartilage. To 
understand this discrepancy, we stained sections of 
control articular chondrocytes with a primary 
TNF-~ antibody from either Sigma Chemical Co. 
or Genzyme Corporation after prior digestion 
with either chondroitinase ABC (0.25 U/ml) or 
hyaluronidase (1.0 mg/ml) for 45 min. We observed 
significant chondrocytic labeling for TNF-~ in all 
cases. These results suggested that differences in 
localization of TNF-~ in control articular cartilage 
between the present study and observations of 
Shinmei et al. [16] and Pickvance t al. [39] may be 
due to potential variations in staining procedures 
or the animals studied. 
In comparison with controls, our first descrip- 
tion of hypercellular articular cartilage appears to 
represent the earliest stage in the etiopathogenesis 
of OA. A generalized intensification of chondro- 
cytic TNF receptor staining was noted throughout 
the thickness of the cartilage, concomitant with a 
generalized ecrease in metachromasia, indicative 
of proteoglycan loss and an increase in matrical 
localization of TNF-~. The apparent increase in 
receptors may not only be an initial degenerative 
change but may also reflect an early compensatory 
action by chondrocytes in response to the increase 
in production and activity of TNF-~ associated 
with proteoglycan loss. 
The second description of hypercellular articu- 
lar cartilage is interpreted as a later degenerative 
stage. Consistent with OA, there was a noticeable 
increase in the thickness of the articular cartilage, 
and the staining patterns for TNF-~, TNF 
receptors, stromelysin and toluidine blue varied 
depending on location. The upper half of the 
articular cartilage had a staining pattern similar 
to the first description of hypercellular articular 
cartilage. However, matrical staining for TNF-a 
was much more intense and loss of proteoglycans 
was greater based on an absence of metachromatic 
staining. A pronounced increase in matrical and 
chondrocytic staining for stromelysin paralleled 
the staining pattern for TNF-~. This was not 
surprising since TNF-~ is capable of up-regulating 
stromelysin as much as 10-fold [24] and stromelysin 
is implicated in matrical degradation in OA 
[16, 22, 23]. 
Chondrocytes in the lower half of the articular 
cartilage had a generalized decrease in TNF 
receptor staining. Although receptor staining in 
both the pericellular and territorial matrices was 
absent, staining was present in the interritorial 
matrix. This suggested secretion of TNF receptors 
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from ~ chondrocytes into the cartilage matrix and 
may represent an attempt at neutralization of 
excess TNF-a by the receptors. In addition, a 
pronounced increase in matrical metachromasia 
paralleled the distribution of TNF receptors. This 
may represent an attempt by the art icular cartilage 
to repair damaged matrix through the increased 
synthesis of proteoglycans, an activity consistent 
with OA [48]. 
In contrast o previous studies [43, 49-51], mild 
to moderate early lesions of OA (based on our 
scoring scheme) were present in the unoperated 
stifles of cranial cruciate-deficient dogs. Rumph 
et al. [52] have reported forced redistribution to 
both front and contralateral rear limbs of dogs" 
with an induced acute synovitis of one stifle joint. 
Forced redistribution has also been demonstrated 
in cruciate-transected dogs [53]. Therefore, it is 
reasonable to assume that surgical destabilization 
of the canine stifle could result in some degree of 
OA in the contralateral rear limb because of forced 
redistribution. 
Although synovial membranes were not specifi- 
cally sampled and analyzed, an interesting obser- 
vations was made from the portion of synovial 
membrane attached to the articular cartilage 
samples. Smooth muscle cells of arteries and 
arterioles demonstrated heavy cellular staining for 
p55, but only in control samples. To our knowledge, 
this is the first report of TNF receptor staining 
in smooth muscle cell nuclei of blood vessels. 
Deleuran et al. [54] reported staining of both p55 
and p75 in endothelial cells of blood vessels and 
perivascular cells. The significance of this obser- 
vation and its potential relationship to OA remains 
to be determined. 
In conclusion, the results of this study suggest 
that TNF-a may be a mediator of normal 
chondrocytic function as well as an instrument of 
art icular cartilage degradation in OA when its 
actions are amplified. Such actions appear to be 
associated with early subtle changes in art icular 
cartilage that should be acknowledged in the 
evaluation and characterization of OA lesions. 
Greater understanding of the genesis of these early 
changes may provide insight into the early 
response of chondrocytes to insults on art icular 
cartilage and therapeutic approaches to arthrit ic 
disease. 
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